JulioARamirezMD

Infectious Disease • Louisville, KY

Professor, Medicine, University of Louisville School of Medicine

Join to view full profile

Dr. Ramirez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ramirez's full profile

Already have an account?

Office
501 E Broadway
Ste 120
Louisville, KY 40202
Phone+1 502-589-4856

Fax+1 502-584-5093

Education & Training

University of Louisville School of MedicineFellowship, Infectious Disease, 1987 - 1989
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1984 - 1987
Universidad Nacional de La Plata Faculty of MedicineClass of 1976

Certifications & Licensure

KY State Medical License 1987 - 2025
IN State Medical License 1991 - 2021
DC State Medical License 1986 - 2013
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Top MD Consumers Checkbook

Clinical Trials

Failure and Cardiovascular Events in Community-acquired Pneumonia Start of enrollment: 2009 Oct 01
Completed
Rapid Empiric Treatment With Oseltamivir Study (RETOS) Start of enrollment: 2010 Nov 01
Completed
Phase 4
Duration of Antibiotic Therapy in Community - Acquired Pneumonia Start of enrollment: 2012 Jan 01
Unknown status
Phase 4
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP Start of enrollment: 2012 Oct 01
Withdrawn
Not Applicable
Patients Response to Early Switch To Oral:Osteomyelitis Study Start of enrollment: 2014 Mar 06
Terminated
Early Phase 1
Join now to see all

Publications & Presentations

PubMed

Challenges of Managing Pulmonary Disease in the Immunocompromised Host.
Guang-Shing Cheng, Julio A Ramirez, Bashar S Staitieh, Scott E Evans
Clinics in Chest Medicine. 2025-03-01
New Perspectives on Antimicrobial Agents: Omadacycline for community-acquired pneumonia, skin and soft tissue infections, and nontuberculous mycobacteria (focus on).
Thomas M File Jr, Julio A Ramirez, Ashley M Wilde
Antimicrobial Agents and Chemotherapy. 2025-02-13
Description of a Current Outbreak ofin the United States.
Anupama Raghuram, Stephen Furmanek, Thomas Chandler, Salwa Rashid, William Mattingly
Pathogens. 2025-01-11

Press Mentions

Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments at IDWeek 2022October 18th, 2022
UofL Researchers Studying Long- and Short-Term Effects of COVID-19May 4th, 2021
HEALTH CARE HEROES: Ruth CarricoApril 8th, 2021
Join now to see all